Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Non-Current Deffered Revenue: 2016-2024

Historic Non-Current Deffered Revenue for Rockwell Medical (RMTI) over the last 8 years, with Dec 2024 value amounting to $429,000.

  • Rockwell Medical's Non-Current Deffered Revenue fell 9.68% to $429,000 in Q4 2024 from the same period last year, while for Dec 2024 it was $429,000, marking a year-over-year decrease of 9.68%. This contributed to the annual value of $429,000 for FY2024, which is 9.68% down from last year.
  • Rockwell Medical's Non-Current Deffered Revenue amounted to $429,000 in Q4 2024, which was down 2.72% from $441,000 recorded in Q3 2024.
  • Rockwell Medical's Non-Current Deffered Revenue's 5-year high stood at $9.5 million during Q1 2020, with a 5-year trough of $429,000 in Q4 2024.
  • Over the past 3 years, Rockwell Medical's median Non-Current Deffered Revenue value was $1.5 million (recorded in 2023), while the average stood at $2.1 million.
  • Data for Rockwell Medical's Non-Current Deffered Revenue shows a maximum YoY tumbled of 89.33% (in 2023) over the last 5 years.
  • Rockwell Medical's Non-Current Deffered Revenue (Quarterly) stood at $8.0 million in 2020, then decreased by 25.32% to $6.0 million in 2021, then crashed by 56.57% to $2.6 million in 2022, then plummeted by 81.73% to $475,000 in 2023, then declined by 9.68% to $429,000 in 2024.
  • Its last three reported values are $429,000 in Q4 2024, $441,000 for Q3 2024, and $452,000 during Q2 2024.